In experiments, we validated that depleting glutathione (GSH), either through the application of the chemical inhibitor BSO or by knocking down its regulatory gene NFE2L2, negatively impacted glioma cell proliferation, colony formation, and migration. Here, NFE2L2 is linked to central nervous system cancer.